Biosimilar medicines: marketing authorisation | European Medicines Agency
The General Court enhances legal protection for producers of generic pharmaceuticals by allowing an incidental plea of illegality against a Commission decision authorising the marketing of a reference medicine | & DE
Brexit: End of Mutual Recognition with the UK - European Directorate for the Quality of Medicines & HealthCare
Good Manufacturing Practice (Gmp) Guidelines: The Rules Governing Medicinal Products in the European Union, Eudralex Volume 4 Concise Reference a book by Mindy J. Allport-Settle
R&D
Towards a Urological European Reference Network: Share, Care and Cure - Uroweb
Medical devices and pharmaceutical products - Publications Office of the EU
Marketing authorisations which are recommended for maintenance and marketing authorisation applications for which bioequivalence
An agency of the European Union - pdf download
Book 4C: 2022 Good Manufacturing Practice in the European Union, Refer – Clinical Research Resources, LLC
Innovator Selection (Reference Medicinal Product) by Mr. Pankaj Dhapa…
PDF) Regulatory overview of biosimilars in Europe
Biosimilar medicines: Overview | European Medicines Agency
Innovator Selection (Reference Medicinal Product) by Mr. Pankaj Dhapa…
Application to the Bulgarian Drug Agency
Reference medicinal products by michelle.gafa
The EU is ready for non-biological complex medicinal products - GaBI Journal
Europe - Biosimilar medicines can be interchanged - RIS.WORLD
Reference pricing systems in Europe: characteristics and - GaBI Journal
E-ALERT | Food & Drug
ad hoc working group on validation issues/national requirements common grounds for invalidation/delaying validation
Frontiers | Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe
CMD(h) WORKING DOCUMENT - INFORMATION TO BE SUBMITTED BY THE MEMBER STATE OF THE EUROPEAN REFERENCE MEDICINAL PRODUCT January 20
European Reference Product - questions and answers
Reference medicinal products by michelle.gafa
Marketing authorization and licensing of medicinal products in EU: Regulatory aspects - ScienceDirect
Untitled
